• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.克隆的α1A/D-肾上腺素能受体亚型的药理学特性与在大鼠大脑皮层和输精管中鉴定出的α1A-肾上腺素能受体一致。
Br J Pharmacol. 1994 Apr;111(4):1003-8. doi: 10.1111/j.1476-5381.1994.tb14843.x.
2
Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.有证据表明,功能性α1A-(α1C-)肾上腺素能受体介导大鼠附睾输精管收缩,而α1B-肾上腺素能受体介导大鼠脾脏收缩。
Br J Pharmacol. 1995 Jun;115(3):467-75. doi: 10.1111/j.1476-5381.1995.tb16356.x.
3
Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.大鼠输精管中α1-肾上腺素能受体亚型的鉴定:结合与功能研究。
Br J Pharmacol. 1992 Nov;107(3):697-704. doi: 10.1111/j.1476-5381.1992.tb14509.x.
4
Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.豚鼠、牛和大鼠α1肾上腺素能受体亚型的比较。
Br J Pharmacol. 1996 Feb;117(4):703-11. doi: 10.1111/j.1476-5381.1996.tb15247.x.
5
Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline.介导大鼠主动脉对去甲肾上腺素收缩反应的α1D肾上腺素能受体的特性研究
Br J Pharmacol. 1995 Jul;115(6):981-6. doi: 10.1111/j.1476-5381.1995.tb15907.x.
6
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.α1肾上腺素能受体拮抗剂在前列腺α1肾上腺素能受体上的药理选择性概况评估:结合、功能及体内研究
Br J Pharmacol. 1996 Jun;118(4):871-8. doi: 10.1111/j.1476-5381.1996.tb15480.x.
7
Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.通过拮抗剂RS 17053区分介导大鼠附睾输精管、大鼠肝门静脉和人类前列腺收缩的α1A-肾上腺素能受体的不同亚型。
Br J Pharmacol. 1996 Sep;119(2):407-15. doi: 10.1111/j.1476-5381.1996.tb16001.x.
8
Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.用乌拉地尔衍生物及其他选择性拮抗剂对α1-肾上腺素能受体识别位点进行亚分类
Br J Pharmacol. 1989 Jul;97(3):691-700. doi: 10.1111/j.1476-5381.1989.tb12005.x.
9
Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.介导大鼠主动脉、输精管和脾脏收缩的α1-肾上腺素能受体亚型的研究。
Br J Pharmacol. 1993 May;109(1):80-7. doi: 10.1111/j.1476-5381.1993.tb13534.x.
10
Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen.人前列腺中α1 -肾上腺素能受体亚型的功能鉴定:与大鼠输精管和脾脏中的受体亚型比较。
Eur J Pharmacol. 1994 Nov 14;265(1-2):61-6. doi: 10.1016/0014-2999(94)90223-2.

引用本文的文献

1
The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.肾上腺素能受体激动剂可乐定可增强选择性κ-阿片受体激动剂依那朵林在单胺耗竭大鼠体内的抗帕金森病作用。
Br J Pharmacol. 1999 Dec;128(7):1577-85. doi: 10.1038/sj.bjp.0702943.
2
A possible structural determinant of selectivity of boldine and derivatives for the alpha 1A-adrenoceptor subtype.去甲坡那定及其衍生物对α1A -肾上腺素能受体亚型选择性的一种可能结构决定因素。
Br J Pharmacol. 1996 Dec;119(8):1563-8. doi: 10.1111/j.1476-5381.1996.tb16073.x.
3
Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.通过拮抗剂RS 17053区分介导大鼠附睾输精管、大鼠肝门静脉和人类前列腺收缩的α1A-肾上腺素能受体的不同亚型。
Br J Pharmacol. 1996 Sep;119(2):407-15. doi: 10.1111/j.1476-5381.1996.tb16001.x.
4
Functional evidence of inverse agonism in vascular smooth muscle.血管平滑肌中反向激动作用的功能证据。
Br J Pharmacol. 1996 Sep;119(1):158-64. doi: 10.1111/j.1476-5381.1996.tb15689.x.
5
Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta.大鼠主动脉中α1肾上腺素能受体拮抗剂活性分析
Br J Pharmacol. 1996 May;118(2):299-310. doi: 10.1111/j.1476-5381.1996.tb15403.x.
6
Investigation of the actions of chloroethylclonidine in rat aorta.氯乙可乐定对大鼠主动脉作用的研究。
Br J Pharmacol. 1995 Aug;115(8):1399-406. doi: 10.1111/j.1476-5381.1995.tb16630.x.
7
Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype.由α1A-(α1C-)肾上腺素能受体亚型介导的人前列腺去甲肾上腺素收缩作用。
Br J Pharmacol. 1995 Jul;115(5):781-6. doi: 10.1111/j.1476-5381.1995.tb15001.x.
8
Comparison of alpha 1A- and alpha 1B-adrenoceptor coupling to inositol phosphate formation in rat kidney.大鼠肾脏中α1A-和α1B-肾上腺素能受体与肌醇磷酸生成偶联的比较
Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec;350(6):592-8. doi: 10.1007/BF00169362.
9
Characterization of alpha 1-adrenoceptor subtypes in tension response of human prostate to electrical field stimulation.人前列腺对电场刺激的张力反应中α1-肾上腺素能受体亚型的特征分析
Br J Pharmacol. 1995 May;115(1):142-6. doi: 10.1111/j.1476-5381.1995.tb16331.x.
10
Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline.介导大鼠主动脉对去甲肾上腺素收缩反应的α1D肾上腺素能受体的特性研究
Br J Pharmacol. 1995 Jul;115(6):981-6. doi: 10.1111/j.1476-5381.1995.tb15907.x.

本文引用的文献

1
Some quantitative uses of drug antagonists.药物拮抗剂的一些定量应用。
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.
2
Characterization of the alpha 1A-adrenoceptors of guinea pig liver membranes: studies using 5-[3H]methylurapidil.豚鼠肝细胞膜α1A - 肾上腺素能受体的特性:使用5 - [3H]甲基脲嘧啶的研究
Mol Pharmacol. 1993 Sep;44(3):589-94.
3
Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.介导大鼠主动脉、输精管和脾脏收缩的α1-肾上腺素能受体亚型的研究。
Br J Pharmacol. 1993 May;109(1):80-7. doi: 10.1111/j.1476-5381.1993.tb13534.x.
4
Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.大鼠脑中α1-肾上腺素能受体亚型的表征:对[3H]WB4104和[3H]哌唑嗪结合的重新评估。
Mol Pharmacol. 1986 Apr;29(4):321-30.
5
Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor.仓鼠α1 - 肾上腺素能受体cDNA的分子克隆与表达
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7159-63. doi: 10.1073/pnas.85.19.7159.
6
Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.用氯乙可乐定和WB 4101区分的α1 - 肾上腺素能受体亚型的比较
Mol Pharmacol. 1988 May;33(5):509-14.
7
Demonstration of alpha 1A- and alpha 1B-adrenoceptor binding sites in human brain tissue.人脑组织中α1A-和α1B-肾上腺素能受体结合位点的显示
Eur J Pharmacol. 1989 Oct 10;169(2-3):325-8. doi: 10.1016/0014-2999(89)90032-0.
8
Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.用乌拉地尔衍生物及其他选择性拮抗剂对α1-肾上腺素能受体识别位点进行亚分类
Br J Pharmacol. 1989 Jul;97(3):691-700. doi: 10.1111/j.1476-5381.1989.tb12005.x.
9
Alpha-adrenoceptors: a critical review.α-肾上腺素能受体:批判性综述。
Med Res Rev. 1989 Oct-Dec;9(4):407-533. doi: 10.1002/med.2610090403.
10
Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle.α1肾上腺素能受体亚型与平滑肌细胞内Ca2+增加的不同机制相关。
Nature. 1987;329(6137):333-5. doi: 10.1038/329333a0.

克隆的α1A/D-肾上腺素能受体亚型的药理学特性与在大鼠大脑皮层和输精管中鉴定出的α1A-肾上腺素能受体一致。

Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.

作者信息

Kenny B A, Naylor A M, Greengrass P M, Russell M J, Friend S J, Read A M, Wyllie M G

机构信息

Department of Discovery Biology, Pfizer Central Research, Sandwich, Kent.

出版信息

Br J Pharmacol. 1994 Apr;111(4):1003-8. doi: 10.1111/j.1476-5381.1994.tb14843.x.

DOI:10.1111/j.1476-5381.1994.tb14843.x
PMID:7913370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1910142/
Abstract
  1. The pharmacological characteristics of cloned mammalian alpha 1A/D-, alpha 1B- and alpha 1C-adrenoceptor subtypes expressed in rat 1 fibroblasts were determined in comparison to the binding and functional properties of these subtypes in rat tissues. 2. Analysis of [3H]-prazosin binding to membrane homogenates from rat 1 fibroblast cells expressing each of the alpha 1-subtypes indicated high affinity binding to a single population of binding sites. Binding affinities were similar for alpha 1A/D-, alpha 1B- and alpha 1C-subtypes (Kds: 0.13, 0.10 and 0.15 nM respectively) although a higher density of alpha 1B- and alpha 1C-receptors (Bmax: 4068 and 10,323 fmol mg-1 protein respectively) were expressed in comparison to alpha 1A/D (838 fmol mg-1). 3. Displacement of [3H]-prazosin from membranes expressing cloned alpha 1-adrenoceptor subtypes revealed that 5-methyl-urapidil, WB 4101, benoxathian and phentolamine displayed high affinity and selectivity for alpha 1A/D- over alpha 1B-subtypes. These compounds also had high affinity and selectivity for alpha 1C- over alpha 1B-subtypes. 5-Methyl-urapidil showed selectivity for alpha 1C (Ki 0.60 +/- 0.16 nM) over both alpha 1A/D (Ki, 9.8 +/- 2.8 nM) and alpha 1B (Ki 57.2 +/- 12 nM) subtypes. Prazosin and doxazosin were not subtype selective. 4. In comparison to [3H]-prazosin a similar pharmacological profile was obtained with [125I]-HEAT using cloned alpha 1A/D-, alpha 1B- and alpha 1C-adrenoceptors expressed in rat 1 fibroblasts. 5. The affinities of prazosin, WB 4101, 5-methyl-urapidil, phentolamine and benoxathian at cloned alpha 1A/D-receptors were consistent with alpha 1A affinities determined with chlorethylclonidine-treated rat cortical membranes. Affinities at cloned XIB-receptors were consistent with alpha 1B affinities determined with rat liver membranes.6. Using the epididymal rat vas deferens as a functional measure of alpha 1A affinity, prazosin (pA29.23 +/- 0.28), WB 4101 (pA2 9.58 +/- 0.12), phentolamine (pKB 7.90 +/- 0.16), benoxathian (pKB 9.21 +/- 0.21)and 5-methyl-urapadil (pKB 8.51 +/-0.16) were potent antagonists of noradrenaline-induced contractions.7. At present, evidence from cloning studies suggests the existence of at least three alpha 1-adrenoceptor subtypes. In contrast to the recent proposal for alpha l-adrenoceptor classification, the pharmacology of the cloned alpha 1A/D (or alpha lD)-adrenoceptor is more consistent with that of an alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.
摘要
  1. 与大鼠组织中这些亚型的结合和功能特性相比较,测定了在大鼠1成纤维细胞中表达的克隆哺乳动物α1A/D -、α1B -和α1C -肾上腺素能受体亚型的药理学特性。2. 对[3H] -哌唑嗪与表达每种α1 -亚型的大鼠1成纤维细胞膜匀浆的结合分析表明,其与单一结合位点群体具有高亲和力。α1A/D -、α1B -和α1C -亚型的结合亲和力相似(解离常数分别为0.13、0.10和0.15 nM),尽管与α1A/D(838 fmol mg-1蛋白质)相比,α1B -和α1C -受体的密度更高(最大结合容量分别为4068和10323 fmol mg-1蛋白质)。3. 从表达克隆α1 -肾上腺素能受体亚型的膜上置换[3H] -哌唑嗪的实验表明,5 -甲基-乌拉地尔、WB 4101、贝诺噻嗪和酚妥拉明对α1A/D -亚型比对α1B -亚型表现出高亲和力和选择性。这些化合物对α1C -亚型比对α1B -亚型也具有高亲和力和选择性。5 -甲基-乌拉地尔对α1C(抑制常数0.60±0.16 nM)的选择性高于α1A/D(抑制常数9.8±2.8 nM)和α1B(抑制常数57.2±12 nM)亚型。哌唑嗪和多沙唑嗪没有亚型选择性。4. 与[3H] -哌唑嗪相比,使用在大鼠1成纤维细胞中表达的克隆α1A/D -、α1B -和α1C -肾上腺素能受体,[125I] -HEAT获得了相似的药理学特征。5. 哌唑嗪、WB 4101、5 -甲基-乌拉地尔、酚妥拉明和贝诺噻嗪在克隆α1A/D -受体上的亲和力与用氯乙可乐定处理的大鼠皮质膜测定的α1A亲和力一致。在克隆α1B -受体上的亲和力与用大鼠肝膜测定的α1B亲和力一致。6. 使用附睾大鼠输精管作为α1A亲和力的功能指标,哌唑嗪(拮抗常数9.2 .3±0.28)、WB 4101(拮抗常数9.58±0.12)、酚妥拉明(拮抗常数7.90±0.16)、贝诺噻嗪(拮抗常数9.21±0.21)和5 -甲基-乌拉地尔(拮抗常数8.51±0.16)是去甲肾上腺素诱导收缩的强效拮抗剂。7. 目前,克隆研究的证据表明至少存在三种α1 -肾上腺素能受体亚型。与最近关于α1 -肾上腺素能受体分类的提议相反,克隆的α1A/D(或α1D)-肾上腺素能受体的药理学与在大鼠大脑皮质和输精管中鉴定的α1A -肾上腺素能受体的药理学更一致。